Your browser doesn't support javascript.
loading
The FACT : Use of a novel intermittent pneumatic compression device to promote pre-surgery arm vein dilation in patients with chronic renal failure.
Hammes, Mary; Desai, Sanjay; Lucas, John F; Mitta, Nivedita; Pulla, Abhishek; Mitra, Amit.
Afiliação
  • Hammes M; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Desai S; Division of Vascular Surgery, MS Ramaiah Medical Center, Bangalore, India.
  • Lucas JF; Department of Surgery, Greenwood Leflore Hospital, Greenwood, MS, USA.
  • Mitta N; Division of Vascular Surgery, MS Ramaiah Medical Center, Bangalore, India.
  • Pulla A; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Mitra A; Department of Systems and Technology, Auburn University, Auburn, AL, USA.
J Vasc Access ; 24(5): 911-919, 2023 Sep.
Article em En | MEDLINE | ID: mdl-34789025
ABSTRACT

BACKGROUND:

Arteriovenous fistula (AVF) creation and maturation for hemodialysis is globally a topic of importance given the poor results and high costs associated with renal care. Successful AVF (surgical or endovascular) creation requires appropriate superficial veins and quality arteries. Many procedures fail due to initial small veins with limited blood flow capacity and distensibility. Intermittent pneumatic compression has previously shown success in trials to increase superficial veins in patients with end stage renal disease post AVF. The objective of this study is to investigate the role of an intermittent pneumatic device, the Fist Assist®, to dilate cephalic arm veins in patients with advanced chronic kidney disease (CKD) prior to AVF placement.

METHODS:

Three centers enrolled subjects from June 2019 through July 2021. Baseline Doppler measurements of the cephalic vein in standard locations the forearm and upper arm with and without a blood pressure cuff were recorded. Patients were instructed and used Fist Assist® on their non-dominant arm for up to 4 h daily for 90 days. At approximately 3 months, Doppler measurements were repeated. The primary endpoint was cephalic vein enlargement with secondary endpoints based on percentage of veins approaching 2.5 mm in the forearm and 3.5 mm in the upper arm.

RESULTS:

Thirty-seven subjects with CKD (mean eGFR 13.8 mL/min) were enrolled and completed the trial. Paired-difference t-tests (one tail) for aggregate data showed significant venous dilation of the cephalic vein in both the forearm and upper arm after use with the Fist Assist® (p < 0.05). Mean differences in the forearm veins were approximately 0.6 and 1.1 mm in the upper arm cephalic vein after Fist Assist® application. There were no major complications reported by any subject during the trial.

CONCLUSIONS:

Fist Assist® use in patients with CKD is effective to enhance vein dilation. Forearm and upper arm cephalic veins increased on average 0.6 and 1.1 mm respectively after Fist Assist® application. This is the first trial to evaluate the effect of intermittent, focal pneumatic compression on pre-surgery vein diameter in patients with advanced CKD before AVF creation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derivação Arteriovenosa Cirúrgica / Insuficiência Renal Crônica / Falência Renal Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derivação Arteriovenosa Cirúrgica / Insuficiência Renal Crônica / Falência Renal Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article